Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian Shahekou District Zhongshan Road No. 467, Dalian 116027, China.
Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian Shahekou District Zhongshan Road No. 467, Dalian 116027, China.
Int J Surg. 2016 Feb;26:32-7. doi: 10.1016/j.ijsu.2016.01.002. Epub 2016 Jan 4.
The relationship between SIRT1 and clinicopathological parameters of colorectal cancer (CRC) is controversial. To evaluate the clinicopathological and prognostic value of silent mating type information regulation 2 homolog-1 (SIRT1) expressions in patients with CRC, a meta-analysis was performed.
We conducted a meta-analysis to investigate the impact of SIRT1 on clinicopathological parameters and prognosis in CRC patients. Studies assessing the relationship between these parameters and SIRT1 expression in CRC were identified up to September, 2015.
Seven studies met the inclusion criteria. Our results showed that SIRT1 expression was correlated with depth of invasion (OR = 0.922, 95% CI: 0.646-1.316, P = 0.005), lymph node metastasis (OR = 1.001, 95% CI: 0.781-1.283, P = 0.000) and TNM stage (OR = 1.103, 95% CI: 0.892-1.365, P = 0.008). Furthermore, we found that SIRT1 expression predicted a poor overall survival (OS) in CRC patients (OR = 1.220, 95% CI: 0.955-1.558, P = 0.037, fixed-effect).
The overall data of the present meta-analysis showed that SIRT1 expression was not correlated with clinicopathological features except for depth of invasion, lymph node metastasis and TNM stage. Simultaneously, SIRT1 overexpression predicted a poor OS in CRC patients, and SIRT1 is a candidate negative prognostic biomarker for CRC patients.
SIRT1 与结直肠癌(CRC)的临床病理参数之间的关系存在争议。为了评估沉默交配型信息调节 2 同源物-1(SIRT1)在 CRC 患者中的临床病理和预后价值,进行了荟萃分析。
我们进行了荟萃分析,以研究 SIRT1 对 CRC 患者临床病理参数和预后的影响。截至 2015 年 9 月,确定了评估这些参数与 CRC 中 SIRT1 表达之间关系的研究。
有 7 项研究符合纳入标准。我们的结果表明,SIRT1 表达与浸润深度(OR = 0.922,95%CI:0.646-1.316,P = 0.005)、淋巴结转移(OR = 1.001,95%CI:0.781-1.283,P = 0.000)和 TNM 分期(OR = 1.103,95%CI:0.892-1.365,P = 0.008)相关。此外,我们发现 SIRT1 表达预测 CRC 患者总体生存(OS)不良(OR = 1.220,95%CI:0.955-1.558,P = 0.037,固定效应)。
本荟萃分析的总体数据表明,SIRT1 表达与临床病理特征无关,除了浸润深度、淋巴结转移和 TNM 分期。同时,SIRT1 过表达预示 CRC 患者 OS 不良,SIRT1 可能是 CRC 患者的一个潜在的负预后生物标志物。